W6134
Based on 1 Customer Validation
W6134 is highly potent and selective RORγ covalent inhibitor with an IC50 of 0.21 μM. W6134 exhibits excellent selectivity for RORγ over RORα, RXRγ, and ERRγ. W6134 significantly inhibits RORγ transcriptional activity W6134 inhibits the proliferation and colony formation and induces apoptosis in castration-resistant prostate cancer cells (CRPC). W6134 can be used for the research of castration-resistant prostate cancers (CRPC).
For research use only. We do not sell to patients.
- Purity : 99.90%
- CAS No.: 2983540-55-0
- Formula: C25H23ClN2O4S
- Molecular Weight:482.98
-
Storage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
|
RORγ 0.21 μM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CWR22R | IC50 |
0.77 μM
Compound: 29
|
Antiproliferative activity against human 22Rv1 cells incubated for 4 days by CCK8 assay
Antiproliferative activity against human 22Rv1 cells incubated for 4 days by CCK8 assay
|
[PMID: 38227771] |
| LNCaP | IC50 |
0.63 μM
Compound: 29
|
Antiproliferative activity against human LNCaP cells incubated for 4 days by CCK8 assay
Antiproliferative activity against human LNCaP cells incubated for 4 days by CCK8 assay
|
[PMID: 38227771] |
| LNCaP C4-2B | IC50 |
0.47 μM
Compound: 29
|
Antiproliferative activity against human LNCaP C4-2B cells incubated for 4 days by CCK8 assay
Antiproliferative activity against human LNCaP C4-2B cells incubated for 4 days by CCK8 assay
|
[PMID: 38227771] |
In Vitro
W6134 (compound 29) has antiproliferative potencies on androgen receptor (AR)-positive human CRPC cell lines, including C4-2B, 22Rv1, and LNCaP, with IC50 values of 0.47 μM, 0.77 μM, and 0.63 μM, respectively[1].
W6134 (1.25-5 μM; 14 days) significantly suppresses the colony formation in C4-2B and 22Rv1 cell lines. W6134 dramatically induces apoptosis of C4-2B and 22Rv1 cells[1].
W6134 (1.25-5 μM; 48 h) inhibits the mRNA levels of AR-regulated genes, such as KLK2, KLK3, and NKX3-1[1].
W6134 (1.25-5 μM; 24-48 h) effectively suppresses the levels of AR or AR-V7 in a dose- and time-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:C4-2B and 22Rv1 cell lines
-
Concentration:1.25 μM, 2.5 μM, 5 μM
-
Incubation Time:14 days
-
Result:Significantly suppressed the colony formation in C4-2B and 22Rv1 cell lines in a dose-dependent manner.
-
Cell Line:C4-2B and 22Rv1 cell lines
-
Concentration:1.25 μM, 2.5 μM, 5 μM
-
Incubation Time:48 h
-
Result:Significantly decreased the expression of AR and its variant AR-V7 in a dose-dependent manner.
The mRNA levels of AR-regulated genes, such as KLK2, KLK3, and NKX3-1, were also dramatically suppressed.
-
Cell Line:C4-2B and 22Rv1 cell lines
-
Concentration:1.25 μM, 2.5 μM, 5 μM
-
Incubation Time:24 h, 48 h, 72 h
-
Result:Effectively suppressed the levels of AR or AR-V7 in a dose- and time-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male NOD/SCID mice (~18 g; 4-week-old) were subcutaneously 22Rv1 cells[1]
-
Dosage:5 mg/kg or 10 mg/kg
-
Administration:i.p; five times per week; for 2 weeks
-
Result:Significantly inhibited the tumor growth in a dose-dependent manner with tumor growth inhibition (TGI) values of 41.90 and 62.58% at doses of 5 and 10 mg/kg.
Chemical Information
-
CAS No. 2983540-55-0
-
Appearance Solid
-
Molecular Weight 482.98
-
Formula C25H23ClN2O4S
-
Color White to off-white
-
SMILES
O=C(NC1=CC=C(C2=C(C=CC=C2)NC(C=C)=O)C(Cl)=C1)CC3=CC=C(C=C3)S(=O)(CC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 83.33 mg/mL (172.53 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Dual Luciferin reporter gene assay
Luciferin reporter gene assay is a reporting system to detect the activity of Firefly Luciferase using luciferin as a substrate, which is often used in the research of miRNA target gene verification and promoter transcriptive activity regulation. Dual luciferase usually refers to Firefly luciferase and Renilla luciferase.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Soft Agar Colony Formation Assay
Soft agar colony formation assay measures anchorage-independent growth, in which transformed or tumorigenic cells proliferate as colonies in a semisolid agar matrix while many non-transformed adherent cells fail to proliferate without attachment; classic studies showed that growth in semisolid medium correlates with tumorigenicity in nude mice, and later protocol papers describe the method as a stringent in vitro assay for malignant transformation. The readout is the number, size, morphology, or signal intensity of colonies formed within agar after incubation; published formats include manual colony counting after staining, 96-well or 384-well quantitative formats, DNA-binding dye detection, MTT/tetrazolium-based detection, digital image analysis, and PCR-based marker detection from soft agar cultures.
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.0705 mL | 10.3524 mL | 20.7048 mL | 51.7620 mL |
| 5 mM | 0.4141 mL | 2.0705 mL | 4.1410 mL | 10.3524 mL | |
| 10 mM | 0.2070 mL | 1.0352 mL | 2.0705 mL | 5.1762 mL | |
| 15 mM | 0.1380 mL | 0.6902 mL | 1.3803 mL | 3.4508 mL | |
| 20 mM | 0.1035 mL | 0.5176 mL | 1.0352 mL | 2.5881 mL | |
| 25 mM | 0.0828 mL | 0.4141 mL | 0.8282 mL | 2.0705 mL | |
| 30 mM | 0.0690 mL | 0.3451 mL | 0.6902 mL | 1.7254 mL | |
| 40 mM | 0.0518 mL | 0.2588 mL | 0.5176 mL | 1.2940 mL | |
| 50 mM | 0.0414 mL | 0.2070 mL | 0.4141 mL | 1.0352 mL | |
| 60 mM | 0.0345 mL | 0.1725 mL | 0.3451 mL | 0.8627 mL | |
| 80 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.6470 mL | |
| 100 mM | 0.0207 mL | 0.1035 mL | 0.2070 mL | 0.5176 mL |